FI884554A0 - Kristallinsk ^-laktamhydrat. - Google Patents
Kristallinsk ^-laktamhydrat.Info
- Publication number
- FI884554A0 FI884554A0 FI884554A FI884554A FI884554A0 FI 884554 A0 FI884554 A0 FI 884554A0 FI 884554 A FI884554 A FI 884554A FI 884554 A FI884554 A FI 884554A FI 884554 A0 FI884554 A0 FI 884554A0
- Authority
- FI
- Finland
- Prior art keywords
- lactamhydrat
- kristallinsk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10576687A | 1987-10-06 | 1987-10-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI884554A0 true FI884554A0 (fi) | 1988-10-04 |
| FI884554A FI884554A (fi) | 1989-04-07 |
Family
ID=22307671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI884554A FI884554A (fi) | 1987-10-06 | 1988-10-04 | Kristallinsk -laktamhydrat. |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0311366B1 (fi) |
| JP (1) | JP2641745B2 (fi) |
| KR (1) | KR970002637B1 (fi) |
| CN (1) | CN1029966C (fi) |
| AR (1) | AR248407A1 (fi) |
| AT (1) | ATE103916T1 (fi) |
| AU (1) | AU598155B2 (fi) |
| BG (1) | BG47036A3 (fi) |
| CA (1) | CA1334970C (fi) |
| CS (1) | CS270594B2 (fi) |
| DD (1) | DD273634A5 (fi) |
| DE (1) | DE3888913T2 (fi) |
| DK (1) | DK170070B1 (fi) |
| EG (1) | EG18529A (fi) |
| ES (1) | ES2063049T3 (fi) |
| FI (1) | FI884554A (fi) |
| HK (1) | HK15497A (fi) |
| HU (1) | HU206348B (fi) |
| IE (1) | IE62108B1 (fi) |
| IL (1) | IL87905A (fi) |
| MX (1) | MX13277A (fi) |
| MY (1) | MY104063A (fi) |
| NO (1) | NO884416L (fi) |
| NZ (1) | NZ226450A (fi) |
| OA (1) | OA08958A (fi) |
| PH (1) | PH31002A (fi) |
| PL (1) | PL152022B1 (fi) |
| PT (1) | PT88662B (fi) |
| SU (1) | SU1731058A3 (fi) |
| UA (1) | UA19149A (fi) |
| YU (1) | YU46699B (fi) |
| ZA (1) | ZA887409B (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD280112A5 (de) * | 1987-10-07 | 1990-06-27 | ����@����@���@��������@���������@�������@�������k�� | Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins |
| CA2002597C (en) * | 1988-11-14 | 1999-03-23 | Thomas M. Eckrich | Solvates of b-lactam antibiotic |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| CA2034592C (en) * | 1990-01-26 | 2001-06-05 | Ralph R. Pfeiffer | Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
| US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
| US5412094A (en) * | 1993-06-28 | 1995-05-02 | Eli Lilly And Company | Bicyclic beta-lactam/paraben complexes |
| US5580977A (en) * | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
| US6001996A (en) * | 1995-05-11 | 1999-12-14 | Eli Lilly And Company | Complexes of cephalosporins and carbacephalosporins with parabens |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| CN100439361C (zh) | 2003-03-07 | 2008-12-03 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| EP1601669B1 (en) | 2003-03-07 | 2008-12-24 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3655656A (en) * | 1970-06-04 | 1972-04-11 | Lilly Co Eli | Crystalline cephalexin monohydrate |
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| DD280112A5 (de) * | 1987-10-07 | 1990-06-27 | ����@����@���@��������@���������@�������@�������k�� | Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins |
-
1988
- 1988-10-03 CA CA000579158A patent/CA1334970C/en not_active Expired - Fee Related
- 1988-10-03 YU YU184588A patent/YU46699B/sh unknown
- 1988-10-03 MY MYPI88001103A patent/MY104063A/en unknown
- 1988-10-03 EG EG506/88A patent/EG18529A/xx active
- 1988-10-03 ZA ZA887409A patent/ZA887409B/xx unknown
- 1988-10-03 DD DD88320417A patent/DD273634A5/de unknown
- 1988-10-04 MX MX1327788A patent/MX13277A/es unknown
- 1988-10-04 IL IL87905A patent/IL87905A/xx active Protection Beyond IP Right Term
- 1988-10-04 PT PT88662A patent/PT88662B/pt not_active IP Right Cessation
- 1988-10-04 PH PH37636A patent/PH31002A/en unknown
- 1988-10-04 AR AR88312109A patent/AR248407A1/es active
- 1988-10-04 FI FI884554A patent/FI884554A/fi not_active Application Discontinuation
- 1988-10-04 AU AU23372/88A patent/AU598155B2/en not_active Expired
- 1988-10-04 DK DK553788A patent/DK170070B1/da active IP Right Grant
- 1988-10-04 NZ NZ226450A patent/NZ226450A/xx unknown
- 1988-10-04 JP JP63251712A patent/JP2641745B2/ja not_active Expired - Fee Related
- 1988-10-04 BG BG85594A patent/BG47036A3/xx unknown
- 1988-10-05 KR KR1019880012961A patent/KR970002637B1/ko not_active IP Right Cessation
- 1988-10-05 AT AT88309261T patent/ATE103916T1/de not_active IP Right Cessation
- 1988-10-05 IE IE301588A patent/IE62108B1/en not_active IP Right Cessation
- 1988-10-05 NO NO88884416A patent/NO884416L/no unknown
- 1988-10-05 EP EP88309261A patent/EP0311366B1/en not_active Expired - Lifetime
- 1988-10-05 UA UA4356543A patent/UA19149A/uk unknown
- 1988-10-05 DE DE3888913T patent/DE3888913T2/de not_active Expired - Lifetime
- 1988-10-05 SU SU884356543A patent/SU1731058A3/ru active
- 1988-10-05 OA OA59444A patent/OA08958A/xx unknown
- 1988-10-05 PL PL1988275093A patent/PL152022B1/pl unknown
- 1988-10-05 ES ES88309261T patent/ES2063049T3/es not_active Expired - Lifetime
- 1988-10-05 CN CN88109140A patent/CN1029966C/zh not_active Expired - Lifetime
- 1988-10-05 HU HU885171A patent/HU206348B/hu unknown
- 1988-10-06 CS CS886666A patent/CS270594B2/cs not_active IP Right Cessation
-
1997
- 1997-02-05 HK HK15497A patent/HK15497A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3880632D1 (de) | Kuevette. | |
| DE3881291D1 (de) | Sehapparat. | |
| DE3862564D1 (de) | Erdanker. | |
| FI77952B (fi) | Ljusbaogsrelae. | |
| DE3867976D1 (de) | Polymergebundene antioxydationsmittel. | |
| FI890901A (fi) | Operationssax. | |
| DE3883705D1 (de) | Alkenylbicyclohexane. | |
| DE3876873D1 (de) | Weblitzenuebergabevorrichtung. | |
| DE3785663D1 (de) | Loetgeraet. | |
| DE3876304T2 (de) | Polysilacylobutasilazane. | |
| DE3882446D1 (de) | Polydisilacyclobutasilazane. | |
| DE3870513D1 (de) | Tennisball. | |
| DE3888991D1 (de) | Aminokohlenwasserstoff-substituierte Ketoximosilane. | |
| FI884554A (fi) | Kristallinsk -laktamhydrat. | |
| DE3877421D1 (de) | Polyamidbenzazole. | |
| FI77055B (fi) | Vaermegradient-inkubator. | |
| DE3879348T2 (de) | Fm-cw-radargeraet. | |
| DE3862309D1 (de) | Aminomethyltetrahydrofurane. | |
| DE3878970D1 (de) | Praeparative chromatographiesaeule. | |
| ES2023228B3 (es) | Ciclopropancarboxamidas. | |
| DE3853279T2 (de) | Laryngoskop. | |
| DE3860710D1 (de) | Exklusiv-oder-schaltung. | |
| DE3860307D1 (de) | 2-aminomethyltetrahydrofurane. | |
| DE3866770D1 (de) | Gerbstoff. | |
| DE3873615D1 (de) | Polycyanoarylthioether. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: ELI LILLY AND COMPANY |